Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Riedinger

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annales De Biologie Clinique|October 30, 2008
[Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy]J-M Riedinger, N Eche, P Fargeot
Annales De Biologie Clinique|June 19, 2008
[Contribution of dynamic interpretation of CA 125 measurements to the understanding of an atypical clinical case]J-M Riedinger, M Mousseau, A-S Gauchez
Annales De Biologie Clinique|October 30, 2008
[Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy]J-M Riedinger, N Eche, C Chevreau, et al.
Annales De Biologie Clinique|February 5, 2009
[PSA kinetics after total prostatectomy]J-M Riedinger, N Eche, Y Fulla, et al.
The Journal of Nutrition, Health & Aging|February 5, 2015
Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cellsA Zarrouk, T Nury, J M Riedinger, et al.
Bulletin Du Cancer|September 1, 1994
[Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters]S Lizard-Nacol, L Arnould, J M Riedinger, et al.
Annales De Biologie Clinique|August 7, 2009
[PSA kinetics after radiotherapy]J-M Riedinger, N Eche, J-M Bachaud, et al.
Bulletin Du Cancer|August 1, 1996
[Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV]J M Riedinger, I Barillot, B Coudert, et al.
Breast Cancer Research : BCR|November 1, 2000
Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancerS Lizard-Nacol, B Coudert, P Colosetti, et al.
Gynecologic Oncology|March 11, 2008
Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric studyJ M Riedinger, N Eche, J P Basuyau, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annales De Biologie Clinique|October 30, 2008
[Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy]J-M Riedinger, N Eche, P Fargeot
Annales De Biologie Clinique|June 19, 2008
[Contribution of dynamic interpretation of CA 125 measurements to the understanding of an atypical clinical case]J-M Riedinger, M Mousseau, A-S Gauchez
Annales De Biologie Clinique|October 30, 2008
[Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy]J-M Riedinger, N Eche, C Chevreau, et al.
Annales De Biologie Clinique|February 5, 2009
[PSA kinetics after total prostatectomy]J-M Riedinger, N Eche, Y Fulla, et al.
The Journal of Nutrition, Health & Aging|February 5, 2015
Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cellsA Zarrouk, T Nury, J M Riedinger, et al.
Bulletin Du Cancer|September 1, 1994
[Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters]S Lizard-Nacol, L Arnould, J M Riedinger, et al.
Annales De Biologie Clinique|August 7, 2009
[PSA kinetics after radiotherapy]J-M Riedinger, N Eche, J-M Bachaud, et al.
Bulletin Du Cancer|August 1, 1996
[Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV]J M Riedinger, I Barillot, B Coudert, et al.
Breast Cancer Research : BCR|November 1, 2000
Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancerS Lizard-Nacol, B Coudert, P Colosetti, et al.
Gynecologic Oncology|March 11, 2008
Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric studyJ M Riedinger, N Eche, J P Basuyau, et al.
Pageof 3